SCHEMBL27228352

SCHEMBL27228352

CC1(C)CN(C(=O)N2CCC3(CCN(Cc4cccc(F)c4)CC3)C2)c2cccnc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 10/20 0.46
▸ CYP3A4 P08684 8/20 0.46
▸ CYP2C9 P11712 6/20 0.46
▸ CYP1A2 P05177 5/20 0.46
▸ CYP2C19 P33261 5/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ TSHR P16473 4/20 0.43
▸ USP2 O75604 4/20 0.43
▸ RECQL P46063 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ HPGD P15428 3/20 0.42
▸ CHRM2 P08172 2/20 0.42
▸ CHRM3 P20309 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ OPRD1 P41143 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31016691 1.00 CYP2D6 (0.46) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL31016709 0.90 CHRM2 (0.44) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL27228300 0.90 CHRM2 (0.44) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL27228311 0.89 CHRM2 (0.53) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL27228298 0.87 GPR6 (0.42) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL31016653 0.87 GPR6 (0.42) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL27228577 0.87 CYP2D6 (0.41) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL27228354 0.86 ALDH1A1 (0.41) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL31016676 0.85 KDM1A (0.41) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL31016661 0.85 DPP4 (0.41) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174671-A1 New 2,3-Dihydro-1H-pyrrolo[3,2-b]pyridine Derivatives as Sigma Ligands ACONDICIONAMIENTO TARRASENSE (ES) 2024-05-30 — — US claimed
US-20240174671-A1 New 2,3-Dihydro-1H-pyrrolo[3,2-b]pyridine Derivatives as Sigma Ligands ACONDICIONAMIENTO TARRASENSE (ES) 2024-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174671-A1 New 2,3-Dihydro-1H-pyrrolo[3,2-b]pyridine Derivatives as Sigma Ligands SIGMAR1, OPRD1, TMEM97 CYP2D6 438/4885CYP3A4 869/4885CYP2C9 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback